December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

248.21 -0.98 (-0.39%)
Official Closing Price Updated: 7:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
17 18 Next >
News headline image
Peering Into ResMed's Recent Short Interest ↗
 
Via Benzinga
News headline image
ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast ↗
Our Elliott Wave analysis updates the Australian Stock Exchange with Resmed Inc shares. We have identified an Expanded Flat correction pattern, indicating the potential for RMD to continue declining... 
Via Talk Markets
News headline image
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
From ResMed Inc.
Via GlobeNewswire
News headline image
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
From ResMed Inc.
Via GlobeNewswire
News headline image
Why NYSE:RMD provides a good dividend, while having solid fundamentals. ↗
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
News headline image
Uncovering Dividend Opportunities with NYSE:RMD. ↗
Why RESMED INC (NYSE:RMD) provides a good dividend, while having solid fundamentals. 
Via Chartmill
News headline image
Cracking The Code: Understanding Analyst Reviews For ResMed ↗
 
Via Benzinga
News headline image
Got $1,000? Buy These Hot Growth Stocks Before They Take Off ↗
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode. 
Via The Motley Fool
News headline image
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
From ResMed Inc.
Via GlobeNewswire
News headline image
MatrixCare Earns Three 2024 Best in KLAS Awards
MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent 
From MatrixCare
Via GlobeNewswire
News headline image
Why ResMed Stock Is Jumping Today ↗
The medical device maker beat expectations with its latest quarterly results. 
Via The Motley Fool
News headline image
Recap: ResMed Q2 Earnings ↗
 
Via Benzinga
News headline image
ResMed's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line ↗
ResMed reported better-than-expected sales and adjusted earnings. 
Via Investor's Business Daily
News headline image
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
News headline image
Why NYSE:RMD provides a good dividend, while having solid fundamentals. ↗
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics. 
Via Chartmill
News headline image
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today ↗
 
Via Benzinga
News headline image
Demystifying ResMed: Insights From 5 Analyst Reviews ↗
 
Via Benzinga
News headline image
Uncovering Dividend Opportunities with NYSE:RMD. ↗
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
News headline image
Earnings Scheduled For January 24, 2024 ↗
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion. 
Via Benzinga
News headline image
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
(RMD) - Analyzing ResMed's Short Interest ↗
 
Via Benzinga
News headline image
3 Stocks to Buy to Benefit From the Booming Sleep Industry ↗
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation. 
Via InvestorPlace
News headline image
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious ↗
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall. 
Via Benzinga
Topics Product Recall
News headline image
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
News headline image
Top Picks 2024: ResMed ↗
ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for... 
Via Talk Markets
News headline image
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.